Listar por autor 

Listar por autor "Adarmes-Gómez, Astrid"  

Mostrando ítems 1-3 de 3

    • Artículo
      Icon

      In vivo cholinergic basal forebrain degeneration and cognition in Parkinson's disease: Imaging results from the COPPADIS study 

      Grothe, Michel J.; Labrador-Espinosa, Miguel Á.; Silvia, Jesús; Macías-García, Daniel; Adarmes-Gómez, Astrid; Carrillo, Fátima; Iglesias Camacho, Elena; Franco-Rosado, Pablo; Roldán Lora, Florinda; Martin Rodríguez, Juan Francisco; Mir Rivera, Pablo; Aguilar Barberá, Miquel; Escalante Arroyo, Sonia; Solano Vila, Berta; de Deus Fonticoba, Teresa; Carrillo Padilla, Francisco; Infante Ceberio, Jon; Hernández Vara, Jorge; de Fábregues Boixar, Oriol; Kulisevsky, Jaime; Martínez Martín, Pablo; Santos García, Diego; Pastor, Pau; Ruíz Martínez, Javier; Cots Foraster, Anna; Pueyo Morlans, Mercedes; Pascual Sedano, Berta; González Aramburu, Isabel (Elsevier, 2021-05-31)
      Introduction: We aimed to assess associations between multimodal neuroimaging measures of cholinergic basal forebrain (CBF) ...
    • Artículo
      IconIcon

      Increased Stroke Risk in Patients with Parkinson’s Disease with LRRK2 Mutations 

      Macías-García, Daniel; Periñán Tocino, María Teresa; Muñoz Delgado, Laura; Jesús, Silvia; Jiménez Jaraba, María Valle; Buiza Rueda, Dolores; Bonilla Toribio, Marta; Adarmes-Gómez, Astrid; Carrillo, Fátima; Gómez Garre, Pilar; Mir Rivera, Pablo (WILEY, 2022)
      Parkinson’s disease (PD) is associated with an increasedstroke risk, however, no relationship between coronary arterydisease ...
    • Artículo
      IconIcon

      Levodopa-induced dyskinesia in Parkinson disease specifically associates with dopaminergic depletion in sensorimotor-related functional subregions of the striatum 

      Labrador-Espinosa, Miguel Á.; Grothe, Michel J.; Macías-García, Daniel; Jesús, Silvia; Adarmes-Gómez, Astrid; Muñoz-Delgado, Laura; Fernández-Rodríguez, Paula; Martín Rodríguez, Juan Francisco; García-Solís, David; Mir Rivera, Pablo (Lippincott, Williams & Wilkins, 2021)
      Purpose: To determine whether the development of levodopa-induced dyskinesia (LID) in Parkinson disease (PD) specifically ...